Keytruda Qlex 395mg (berahyaluronidase alfa/pembrolizumab)

Original price was: $10,000.00.Current price is: $7,500.00.

Keytruda Qlex 395mg (berahyaluronidase alfa/pembrolizumab) is a subcutaneous immunotherapy for cancer treatment. It combines pembrolizumab with a delivery-enhancing enzyme for faster, convenient administration. Ideal for lymphoma and advanced cancers, with detailed dosing, side effect, and administration guidance.